FDA warns Dollar Tree for failure to remove recalled children’s food

See what’s clicking on FoxBusiness.com The US Food and Drug Administration (FDA) sent a warning letter to Dollar Tree, Inc. last week after an investigation found the company failed to remove baby food containing high levels of lead and chromium, 45 days after it was notified of its recall. . WanaBana issued a voluntary recall … Read more

FDA extends approval of first gene therapy for rare form of muscular dystrophy

CNN – The US Food and Drug Administration has given the green light for the first gene therapy to treat a rare form of muscular dystrophy to be used in most people who have the disease and a certain genetic mutation. Last year, the drug – Elevidys, from the biotech company Sarepta Therapeutics – was … Read more

FDA expands approval of gene therapy for patients with Duchenne muscular dystrophy

For immediate release: June 20, 2024 Today, the US Food and Drug Administration extended the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in DMD gene. Elevidys was previously approved … Read more